Advanced Therapies Week 2027

ARMI | BioFabUSA is pleased to partner with Phacilitate for Advanced Therapies Week 2027, a leading industry gathering bringing together innovators, manufacturers, investors, and technology developers working to advance cell and gene therapies and next-generation biotherapeutics.

The four-day event provides opportunities to explore emerging technologies, manufacturing challenges, commercialization strategies, and the partnerships needed to move advanced therapies toward clinical and commercial applications.

ARMI | BioFabUSA Participation

As part of its collaboration with Phacilitate, ARMI will contribute to programming focused on supporting emerging companies and advancing manufacturing readiness.

ARMI’s involvement includes the Founders Forum on January 18, where discussions will explore considerations for companies navigating the transition from early-stage innovation toward scalable manufacturing and commercialization.

Topics are expected to include:

• Manufacturing readiness and scale-up strategies
• Clinical development and CMC considerations
• Quality and regulatory planning
• Financing and commercialization pathways
• Partnerships and manufacturing infrastructure for emerging companies

Additional details regarding ARMI participation and speakers will be announced as programming is finalized.

ARMI | BioFabUSA Member Opportunities

As an event partner, ARMI | BioFabUSA is pleased to help connect our members with opportunities to participate in Advanced Therapies Week 2027.

BioFabUSA members interested in attending are encouraged to contact our team at outreach_membership@armiusa.org to learn more about available registration benefits and opportunities to engage with the ARMI community during the event.

Learn More & Register: Advanced Therapies Week 2027